GlaxoSmithKline's new diabetes med faces formidable GLP-1 foes | PharmaBoardroom
written on 16.04.2014
Tags:
,

GlaxoSmithKline's new diabetes med faces formidable GLP-1 foes

TAGS: ,

GlaxoSmithKline's albiglutide, now dubbed Tanzeum for the U.S. market, nabbed FDA approval Tuesday.

Latest Report